Lista de obras - Maeve Lowery - Dominio Público Uruguay

(90)Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapies

artículo científico publicado en 2015

A 67-year-old woman with BRCA 1 mutation associated with pancreatic adenocarcinoma

artículo científico publicado en 2011

A 72-year-old man with duodenal adenocarcinoma ⬇️

artículo científico publicado el 1 de mayo de 2012

A Combination of Radiation and the Hypoxia-Activated Prodrug Evofosfamide (TH-302) is Efficacious against a Human Orthotopic Pancreatic Tumor Model.

artículo científico publicado en 2017

A case of advanced gastric cancer.

artículo científico publicado en 2012

A man with Klinefelter's syndrome and new abdominal distension: a discussion of evaluation and management

artículo científico publicado en 2012

A phase 1/1B trial of ADI-PEG 20 plus nab-paclitaxel and gemcitabine in patients with advanced pancreatic adenocarcinoma.

artículo científico publicado en 2017

A phase II, open-label, multicenter study to evaluate the antitumor efficacy of CO-1.01 as second-line therapy for gemcitabine-refractory patients with stage IV pancreatic adenocarcinoma and negative tumor hENT1 expression

artículo científico publicado en 2014

A single-arm, nonrandomized phase II trial of neoadjuvant gemcitabine and oxaliplatin in patients with resectable pancreas adenocarcinoma

artículo científico publicado en 2014

A woman with remotely treated pancreas cancer and new abdominal pain: a discussion of evaluation and management

artículo científico publicado en 2011

Acinar cell carcinoma of the pancreas: new genetic and treatment insights into a rare malignancy.

artículo científico publicado en 2011

Advances in cholangiocarcinoma research: report from the third Cholangiocarcinoma Foundation Annual Conference

artículo científico publicado en 2016

Ampullary cancer: Evaluation of somatic and germline genetic alterations and association with clinical outcomes

scientific article published on 08 January 2019

An emerging entity: pancreatic adenocarcinoma associated with a known BRCA mutation: clinical descriptors, treatment implications, and future directions

artículo científico publicado en 2011

Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial

scientific article published on 31 October 2019

Biliary carcinomas: pathology and the role of DNA mismatch repair deficiency.

artículo científico publicado en 2016

Brain Metastases in Pancreatic Ductal Adenocarcinoma: Assessment of Molecular Genotype-Phenotype Features-An Entity With an Increasing Incidence?

artículo científico publicado en 2018

Case report: primary acinar cell carcinoma of the liver treated with multimodality therapy

artículo científico publicado en 2017

Circulating Tumor and Invasive Cell Gene Expression Profile Predicts Treatment Response and Survival in Pancreatic Adenocarcinoma

article

Clinical pharmacokinetics and pharmacodynamics of ivosidenib, an oral, targeted inhibitor of mutant IDH1, in patients with advanced solid tumors

scientific article published on 26 April 2019

Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention

scientific article published on 30 May 2018

Current management and future directions in metastatic pancreatic adenocarcinoma.

artículo científico publicado en 2016

DNA mismatch repair abnormalities in acinar cell carcinoma of the pancreas: frequency and clinical significance

artículo científico publicado en 2014

Erratum: Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients

artículo científico publicado en 2017

Evaluating Mismatch Repair Deficiency in Pancreatic Adenocarcinoma: Challenges and Recommendations.

artículo científico publicado en 2018

FOLFIRINOX Induction Therapy for Stage 3 Pancreatic Adenocarcinoma

artículo científico publicado en 2015

Frequency, Morbidity, and Mortality of Bone Metastases in Advanced Hepatocellular Carcinoma.

artículo científico publicado en 2018

Gastrointestinal cancer educational case series: management of metastatic adenocarcinoma of unknown primary origin in a Ph+ ALL survivor

artículo científico publicado en 2011

Gastrointestinal cancer educational case series: the history and management of complex cases in gi oncology. A 72 year-old man with metastatic gastric cancer

artículo científico publicado en 2011

Genomic Landscape of Pancreatic Adenocarcinoma in Younger versus Older Patients: Does Age Matter?

artículo científico publicado en 2019

Genomic instability in pancreatic adenocarcinoma: a new step towards precision medicine and novel therapeutic approaches.

artículo científico publicado en 2016

Genomics and pharmacogenomics of pancreatic adenocarcinoma ⬇️

artículo científico publicado el 20 de diciembre de 2011

Genotype-phenotype correlation in BRCA1/2 mutation-associated pancreatic cancer

scientific article published on 02 December 2019

Hepatocellular carcinoma following renal transplantation.

artículo científico publicado en 2011

Identification of germline genetic mutations in patients with pancreatic cancer

artículo científico publicado en 2015

In Vitro and In Vivo Comparison of Gemcitabine and the Gemcitabine Analog 1-(2'-deoxy-2'-fluoroarabinofuranosyl) Cytosine (FAC) in Human Orthotopic and Genetically Modified Mouse Pancreatic Cancer Models.

artículo científico publicado en 2017

Incidence, Management, and Implications of Visceral Thrombosis in Pancreatic Ductal Adenocarcinoma.

artículo científico publicado en 2018

Isoform switching as a mechanism of acquired resistance to mutant isocitrate dehydrogenase inhibition

article

Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing.

artículo científico publicado en 2017

Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.

artículo científico publicado en 2017

New approaches to the treatment of pancreatic cancer: from tumor-directed therapy to immunotherapy

artículo científico publicado en 2011

Novel Therapeutics for Pancreatic Adenocarcinoma

artículo científico

OncoKB: A Precision Oncology Knowledge Base

scientific article published on 16 May 2017

Pancreas Adenocarcinoma: Ascites, Clinical Manifestations, and Management Implications.

artículo científico publicado en 2016

Pancreatic adenocarcinoma: new approaches to a challenging malignancy

artículo científico publicado el 1 de diciembre de 2010

Pancreatic cancer: the role of molecular markers in diagnosis and management

artículo científico publicado el 1 de diciembre de 2011

Pharmacogenomic modeling of circulating tumor and invasive cells for prediction of chemotherapy response and resistance in pancreatic cancer

artículo científico publicado en 2014

Phase 1 trial evaluating cisplatin, gemcitabine, and veliparib in 2 patient cohorts: Germline BRCA mutation carriers and wild-type BRCA pancreatic ductal adenocarcinoma

artículo científico publicado en 2018

Phase 1b study of a small molecule antagonist of human chemokine (C-C motif) receptor 2 (PF-04136309) in combination with nab-paclitaxel/gemcitabine in first-line treatment of metastatic pancreatic ductal adenocarcinoma

artículo científico publicado en 2019

Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma.

artículo científico publicado en 2017

Phase II trial of veliparib in patients with previously treated BRCA-mutated pancreas ductal adenocarcinoma

artículo científico publicado en 2017

Postresection surveillance for pancreatic cancer performance status, imaging, and serum markers.

artículo científico publicado en 2012

Preliminary study of tumor heterogeneity in imaging predicts two year survival in pancreatic cancer patients.

artículo científico publicado en 2017

Prevalence of pancreaticobiliary cancers in Irish families with pathogenic BRCA1 and BRCA2 variants

scientific article published on 12 September 2020

Prospective Evaluation of Germline Alterations in Patients With Exocrine Pancreatic Neoplasms

artículo científico publicado en 2018

Re: Lymphopenia associated with adjuvant anthracycline/taxane regimens.

artículo científico publicado en 2009

Real-Time Genomic Profiling of Pancreatic Ductal Adenocarcinoma: Potential Actionability and Correlation with Clinical Phenotype

artículo científico publicado en 2017

Reverse-Contrast Imaging and Targeted Radiation Therapy of Advanced Pancreatic Cancer Models.

artículo científico publicado en 2015

Second-line chemotherapy in advanced biliary cancers: A retrospective, multicenter analysis of outcomes

scientific article published on 27 August 2019

Stereotactic body radiation vs. intensity-modulated radiation for unresectable pancreatic cancer.

artículo científico publicado en 2017

Systemic Chemotherapy Combined with Resection for Locally Advanced Gallbladder Carcinoma: Surgical and Survival Outcomes

artículo científico publicado en 2017

Systemic therapy for biliary cancers.

artículo científico publicado en 2016

Targeted therapies for pancreatic adenocarcinoma.

artículo científico publicado en 2009

The role of novel biologics in biliary cancers

artículo científico publicado en 2016

Treatment of metastatic pancreatic adenocarcinoma: new options and promising strategies

artículo científico publicado en 2014

Treatment, Outcomes, and Clinical Trial Participation in Elderly Patients With Metastatic Pancreas Adenocarcinoma

artículo científico publicado en 2015

Visceral Thromboses in Pancreas Adenocarcinoma: Systematic Review.

artículo científico publicado en 2017

Young patients with synchronous colorectal liver metastases.

scientific article published on April 2016

Lista de obras de Maeve Lowery

(90)Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapies

A 67-year-old woman with BRCA 1 mutation associated with pancreatic adenocarcinoma

A 72-year-old man with duodenal adenocarcinoma ⬇️

A Combination of Radiation and the Hypoxia-Activated Prodrug Evofosfamide (TH-302) is Efficacious against a Human Orthotopic Pancreatic Tumor Model.

A case of advanced gastric cancer.

A man with Klinefelter's syndrome and new abdominal distension: a discussion of evaluation and management

A phase 1/1B trial of ADI-PEG 20 plus nab-paclitaxel and gemcitabine in patients with advanced pancreatic adenocarcinoma.

A phase II, open-label, multicenter study to evaluate the antitumor efficacy of CO-1.01 as second-line therapy for gemcitabine-refractory patients with stage IV pancreatic adenocarcinoma and negative tumor hENT1 expression

A single-arm, nonrandomized phase II trial of neoadjuvant gemcitabine and oxaliplatin in patients with resectable pancreas adenocarcinoma

A woman with remotely treated pancreas cancer and new abdominal pain: a discussion of evaluation and management

Acinar cell carcinoma of the pancreas: new genetic and treatment insights into a rare malignancy.

Advances in cholangiocarcinoma research: report from the third Cholangiocarcinoma Foundation Annual Conference

Ampullary cancer: Evaluation of somatic and germline genetic alterations and association with clinical outcomes

An emerging entity: pancreatic adenocarcinoma associated with a known BRCA mutation: clinical descriptors, treatment implications, and future directions

Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial

Biliary carcinomas: pathology and the role of DNA mismatch repair deficiency.

Brain Metastases in Pancreatic Ductal Adenocarcinoma: Assessment of Molecular Genotype-Phenotype Features-An Entity With an Increasing Incidence?

Case report: primary acinar cell carcinoma of the liver treated with multimodality therapy

Circulating Tumor and Invasive Cell Gene Expression Profile Predicts Treatment Response and Survival in Pancreatic Adenocarcinoma

Clinical pharmacokinetics and pharmacodynamics of ivosidenib, an oral, targeted inhibitor of mutant IDH1, in patients with advanced solid tumors

Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention

Current management and future directions in metastatic pancreatic adenocarcinoma.

DNA mismatch repair abnormalities in acinar cell carcinoma of the pancreas: frequency and clinical significance

Erratum: Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients

Evaluating Mismatch Repair Deficiency in Pancreatic Adenocarcinoma: Challenges and Recommendations.

FOLFIRINOX Induction Therapy for Stage 3 Pancreatic Adenocarcinoma

Frequency, Morbidity, and Mortality of Bone Metastases in Advanced Hepatocellular Carcinoma.

Gastrointestinal cancer educational case series: management of metastatic adenocarcinoma of unknown primary origin in a Ph+ ALL survivor

Gastrointestinal cancer educational case series: the history and management of complex cases in gi oncology. A 72 year-old man with metastatic gastric cancer

Genomic Landscape of Pancreatic Adenocarcinoma in Younger versus Older Patients: Does Age Matter?

Genomic instability in pancreatic adenocarcinoma: a new step towards precision medicine and novel therapeutic approaches.

Genomics and pharmacogenomics of pancreatic adenocarcinoma ⬇️

Genotype-phenotype correlation in BRCA1/2 mutation-associated pancreatic cancer

Hepatocellular carcinoma following renal transplantation.

Identification of germline genetic mutations in patients with pancreatic cancer

In Vitro and In Vivo Comparison of Gemcitabine and the Gemcitabine Analog 1-(2'-deoxy-2'-fluoroarabinofuranosyl) Cytosine (FAC) in Human Orthotopic and Genetically Modified Mouse Pancreatic Cancer Models.

Incidence, Management, and Implications of Visceral Thrombosis in Pancreatic Ductal Adenocarcinoma.

Isoform switching as a mechanism of acquired resistance to mutant isocitrate dehydrogenase inhibition

Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing.

Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.

New approaches to the treatment of pancreatic cancer: from tumor-directed therapy to immunotherapy

Novel Therapeutics for Pancreatic Adenocarcinoma

OncoKB: A Precision Oncology Knowledge Base

Pancreas Adenocarcinoma: Ascites, Clinical Manifestations, and Management Implications.

Pancreatic adenocarcinoma: new approaches to a challenging malignancy

Pancreatic cancer: the role of molecular markers in diagnosis and management

Pharmacogenomic modeling of circulating tumor and invasive cells for prediction of chemotherapy response and resistance in pancreatic cancer

Phase 1 trial evaluating cisplatin, gemcitabine, and veliparib in 2 patient cohorts: Germline BRCA mutation carriers and wild-type BRCA pancreatic ductal adenocarcinoma

Phase 1b study of a small molecule antagonist of human chemokine (C-C motif) receptor 2 (PF-04136309) in combination with nab-paclitaxel/gemcitabine in first-line treatment of metastatic pancreatic ductal adenocarcinoma

Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma.

Phase II trial of veliparib in patients with previously treated BRCA-mutated pancreas ductal adenocarcinoma

Postresection surveillance for pancreatic cancer performance status, imaging, and serum markers.

Preliminary study of tumor heterogeneity in imaging predicts two year survival in pancreatic cancer patients.

Prevalence of pancreaticobiliary cancers in Irish families with pathogenic BRCA1 and BRCA2 variants

Prospective Evaluation of Germline Alterations in Patients With Exocrine Pancreatic Neoplasms

Re: Lymphopenia associated with adjuvant anthracycline/taxane regimens.

Real-Time Genomic Profiling of Pancreatic Ductal Adenocarcinoma: Potential Actionability and Correlation with Clinical Phenotype

Reverse-Contrast Imaging and Targeted Radiation Therapy of Advanced Pancreatic Cancer Models.

Second-line chemotherapy in advanced biliary cancers: A retrospective, multicenter analysis of outcomes

Stereotactic body radiation vs. intensity-modulated radiation for unresectable pancreatic cancer.

Systemic Chemotherapy Combined with Resection for Locally Advanced Gallbladder Carcinoma: Surgical and Survival Outcomes

Systemic therapy for biliary cancers.

Targeted therapies for pancreatic adenocarcinoma.

The role of novel biologics in biliary cancers

Treatment of metastatic pancreatic adenocarcinoma: new options and promising strategies

Treatment, Outcomes, and Clinical Trial Participation in Elderly Patients With Metastatic Pancreas Adenocarcinoma

Visceral Thromboses in Pancreas Adenocarcinoma: Systematic Review.

Young patients with synchronous colorectal liver metastases.